Mira Pharmaceuticals Inc (NASDAQ: MIRA) on Monday, soared 0.48% from the previous trading day, before settling in for the closing price of $2.10. Within the past 52 weeks, MIRA’s price has moved between $0.51 and $7.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 20.31%. With a float of $9.52 million, this company’s outstanding shares have now reached $14.78 million.
Considering the fact that the conglomerate employs 3 people, you should pay attention to its efficiency factor.
Mira Pharmaceuticals Inc (MIRA) Insider Activity
Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of Mira Pharmaceuticals Inc is 35.60%, while institutional ownership is 4.85%. The most recent insider transaction that took place on May 21 ’24, was worth 8,176. In this transaction Chief Executive Officer of this company bought 8,700 shares at a rate of $0.94, taking the stock ownership to the 382,200 shares. Before that another transaction happened on Dec 11 ’23, when Company’s 10% Owner sold 46,005 for $1.55, making the entire transaction worth $71,496. This insider now owns 660,000 shares in total.
Mira Pharmaceuticals Inc (MIRA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.31% per share during the next fiscal year.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Trading Performance Indicators
Mira Pharmaceuticals Inc (MIRA) is currently performing well based on its current performance indicators. A quick ratio of 5.70 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of Mira Pharmaceuticals Inc (MIRA)
Compared to the last year’s volume of 2.33 million, its volume of 1.52 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 27.46%. Additionally, its Average True Range was 0.50.
During the past 100 days, Mira Pharmaceuticals Inc’s (MIRA) raw stochastic average was set at 35.56%, which indicates a significant increase from 13.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 171.71% in the past 14 days, which was lower than the 349.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.27, while its 200-day Moving Average is $1.33. Nevertheless, the first resistance level for the watch stands at $2.24 in the near term. At $2.36, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.53. If the price goes on to break the first support level at $1.95, it is likely to go to the next support level at $1.78. Should the price break the second support level, the third support level stands at $1.66.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Key Stats
Market capitalization of the company is 31.19 million based on 14,781K outstanding shares. Right now, sales total 0 K and income totals -11,980 K. The company made 0 K in profit during its latest quarter, and -1,720 K in sales during its previous quarter.
